165 related articles for article (PubMed ID: 12705852)
21. A continuous central motif of invariant chain peptides, CLIP, is essential for binding to various I-A MHC class II molecules.
Weenink SM; Milburn PJ; Gautam AM
Int Immunol; 1997 Feb; 9(2):317-25. PubMed ID: 9040013
[TBL] [Abstract][Full Text] [Related]
22. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation.
Hsieh CS; deRoos P; Honey K; Beers C; Rudensky AY
J Immunol; 2002 Mar; 168(6):2618-25. PubMed ID: 11884425
[TBL] [Abstract][Full Text] [Related]
23. Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation.
Lankar D; Vincent-Schneider H; Briken V; Yokozeki T; Raposo G; Bonnerot C
J Exp Med; 2002 Feb; 195(4):461-72. PubMed ID: 11854359
[TBL] [Abstract][Full Text] [Related]
24. Interaction of HLA-DR and CD74 at the cell surface of antigen-presenting cells by single particle image analysis.
Karakikes I; Morrison IE; O'Toole P; Metodieva G; Navarrete CV; Gomez J; Miranda-Sayago JM; Cherry RJ; Metodiev M; Fernandez N
FASEB J; 2012 Dec; 26(12):4886-96. PubMed ID: 22889831
[TBL] [Abstract][Full Text] [Related]
25. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner.
Lautwein A; Kraus M; Reich M; Burster T; Brandenburg J; Overkleeft HS; Schwarz G; Kammer W; Weber E; Kalbacher H; Nordheim A; Driessen C
J Leukoc Biol; 2004 May; 75(5):844-55. PubMed ID: 14966190
[TBL] [Abstract][Full Text] [Related]
26. The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.
Fujii S; Senju S; Chen YZ; Ando M; Matsushita S; Nishimura Y
Hum Immunol; 1998 Oct; 59(10):607-14. PubMed ID: 9757942
[TBL] [Abstract][Full Text] [Related]
27. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing.
Manoury B; Gregory WF; Maizels RM; Watts C
Curr Biol; 2001 Mar; 11(6):447-51. PubMed ID: 11301256
[TBL] [Abstract][Full Text] [Related]
28. Cathepsins and compartmentalization in antigen presentation.
Riese RJ; Chapman HA
Curr Opin Immunol; 2000 Feb; 12(1):107-13. PubMed ID: 10679409
[TBL] [Abstract][Full Text] [Related]
29. MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation.
Gregers TF; Fleckenstein B; Vartdal F; Roepstorff P; Bakke O; Sandlie I
Int Immunol; 2003 Nov; 15(11):1291-9. PubMed ID: 14565927
[TBL] [Abstract][Full Text] [Related]
30. The MHC class II-associated invariant chain-derived peptide clip binds to the peptide-binding groove of class II molecules.
Wu S; Gorski J
Mol Immunol; 1996; 33(4-5):371-7. PubMed ID: 8676888
[TBL] [Abstract][Full Text] [Related]
31. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading.
Riese RJ; Wolf PR; Brömme D; Natkin LR; Villadangos JA; Ploegh HL; Chapman HA
Immunity; 1996 Apr; 4(4):357-66. PubMed ID: 8612130
[TBL] [Abstract][Full Text] [Related]
32. Coalescence of B cell receptor and invariant chain MHC II in a raft-like membrane domain.
Hauser JT; Lindner R
J Leukoc Biol; 2014 Nov; 96(5):843-55. PubMed ID: 25024398
[TBL] [Abstract][Full Text] [Related]
33. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
[TBL] [Abstract][Full Text] [Related]
34. Intracellular transport of MHC class II and associated invariant chain in antigen presenting cells from AP-3-deficient mocha mice.
Sevilla LM; Richter SS; Miller J
Cell Immunol; 2001 Jun; 210(2):143-53. PubMed ID: 11520080
[TBL] [Abstract][Full Text] [Related]
35. Trafficking of major histocompatibility complex class II molecules through intracellular compartments containing HLA-DM.
Robbins NF; Hammond C; Denzin LK; Pan M; Cresswell P
Hum Immunol; 1996 Jan; 45(1):13-23. PubMed ID: 8655355
[TBL] [Abstract][Full Text] [Related]
36. Invariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines.
Dolan BP; Phelan TP; Ilkovitch D; Qi L; Wade WF; Laufer TM; Ostrand-Rosenberg S
J Immunol; 2004 Jan; 172(2):907-14. PubMed ID: 14707062
[TBL] [Abstract][Full Text] [Related]
37. Presentation by recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification.
Sinnathamby G; Eisenlohr LC
J Immunol; 2003 Apr; 170(7):3504-13. PubMed ID: 12646611
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of invariant chain processing, antigen-induced proliferative responses, and the development of collagen-induced arthritis and experimental autoimmune encephalomyelitis by a small molecule cysteine protease inhibitor.
Podolin PL; Bolognese BJ; Carpenter DC; Davis TG; Johanson RA; Fox JH; Long E; Dong X; Marquis RW; Locastro SM; Terfloth GJ; Kurali E; Peterson JJ; Smith BR; McQueney MS; Yamashita DS; Capper-Spudich EA
J Immunol; 2008 Jun; 180(12):7989-8003. PubMed ID: 18523262
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of the reactions between the invariant chain (85-99) peptide and proteins of the murine class II MHC.
Liang MN; Beeson C; Mason K; McConnell HM
Int Immunol; 1995 Sep; 7(9):1397-404. PubMed ID: 7495747
[TBL] [Abstract][Full Text] [Related]
40. CLIP-region mediated interaction of Invariant chain with MHC class I molecules.
Powis SJ
FEBS Lett; 2006 May; 580(13):3112-6. PubMed ID: 16678175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
